StonvexLoading…
StonvexStonvexStonvexCore line items from AR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.90B | $5.14B | $3.82B | $2.65B |
Operating Income | $729.45M | $883.65M | $594.47M | $476.36M |
Net Income | $548.21M | $674.57M | $471.65M | $166.57M |
EPS (Diluted) | $1.72 | $2.03 | $1.41 | $1.16 |
Total Assets | $15.35B | $13.25B | $12.91B | $12.77B |
Total Liabilities | $7.13B | $5.53B | $5.39B | $5.28B |
Cash & Equivalents | $0.00 | $210.00M | $0.00 | $0.00 |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 309.82M | 308.51M | 308.38M | 309.87M |